Katrijn L M Michielsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katrijn L M Michielsen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Frederik De Keyzer
Department of Radiology, University Hospitals Leuven, Leuven, Belgium
2 shared publications - Frédéric Amant
Department of oncology, KU Leuven, Leuven, Belgium
2 shared publications - Ignace Vergote
University Hospital Leuven, Leuven Cancer Institute , Leuven, Belgium, European Union
2 shared publications - Philippe Moerman
Department of Pathology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium
2 shared publications - Ragna Vanslembrouck
University Hospitals Leuven
2 shared publications - Raphaëla Dresen
Department of Radiology, University Hospitals Leuven, Leuven, 3000, Belgium
2 shared publications
Latest Publications
- 1 September 2017
- Published by Elsevier in European Journal of Cancer
- Vol. 83, 88-98
Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
- 1 September 2017
- Published by Elsevier in European Journal of Cancer
- Vol. 83, 88-98
Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer
- 1 November 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1067) , 20160468
Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study
Objective:To assess the clinical feasibility of whole-body diffusion-weighted MRI (WB-DWI/MRI) for diagnosis and prediction of complete tumour resection in patients with suspected recurrent ovarian cancer.Methods:51 females clinically suspected for ovarian cancer recurrence underwent 3-T WB-DWI/MRI in addition to contrast-enhanced CT. WB-DWI/MRI was assessed for detection of tumour recurrence, prediction of tumour extent and complete resection compared with CT. Tumour presence was confirmed by pathology obtained by surgery or biopsy, or by imaging follow-up.Results:WB-DWI/MRI showed 94% accuracy for detecting ovarian cancer recurrence, compared with 78% for CT (p = 0.008). WB-DWI/MRI showed better sensitivity [% (95% confidence interval)] than CT for detecting involvement of surgically critical tumour sites including mesenteric root infiltration [92 (62–100) vs 31 (10–61)], small bowel [93 (64–100) vs 21 (6–51)], colon carcinomatosis [91 (57–100) vs 27 (7–61)] and unresectable distant metastases [90 (54–9...
- 1 November 2016
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 89 (1067) , 20160468
Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study
Objective:To assess the clinical feasibility of whole-body diffusion-weighted MRI (WB-DWI/MRI) for diagnosis and prediction of complete tumour resection in patients with suspected recurrent ovarian cancer.Methods:51 females clinically suspected for ovarian cancer recurrence underwent 3-T WB-DWI/MRI in addition to contrast-enhanced CT. WB-DWI/MRI was assessed for detection of tumour recurrence, prediction of tumour extent and complete resection compared with CT. Tumour presence was confirmed by pathology obtained by surgery or biopsy, or by imaging follow-up.Results:WB-DWI/MRI showed 94% accuracy for detecting ovarian cancer recurrence, compared with 78% for CT (p = 0.008). WB-DWI/MRI showed better sensitivity [% (95% confidence interval)] than CT for detecting involvement of surgically critical tumour sites including mesenteric root infiltration [92 (62–100) vs 31 (10–61)], small bowel [93 (64–100) vs 21 (6–51)], colon carcinomatosis [91 (57–100) vs 27 (7–61)] and unresectable distant metastases [90 (54–9...